Acne treatment gets US approval
NICK KRAUSE
Kiwi company Douglas Pharmaceuticals has won approval to sell its locally developed acne medication in the United States.
The Auckland company has been trying for a decade to break into the US acne medication market, which is worth about US$400 million (NZ$494m).
its new medication, isotretinoin, now has Food and Drug Administration approval.
The company is new Zealand’s largest manufacturer of pharmaceuticals, specialising in immuno-suppression, central nervous system, oncology and dermatology products.
It already sells to 35 countries, with an export turnover of $85m.
Director Jeff Douglas said in a statement that it was a breakthrough and would …
Read User's Comments0